Pfizer and German partner BioNTech said Monday they're seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children aged 5 to...
(Reuters) -Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "I’m feeling well and symptom free," Bourla said in a statement....
Pfizer CEO Has COVID For Second Time In Two Months Pfizer CEO Albert Bourla has tested positive for Covid-19 for the second time in two months. The 60-year-old contracted the...
Fauci, Klain, Yellen, Kendi Headline Pfizer-Funded, Far-Left Conference In D.C. This Week Authored by Raheem J. Kassam and Natalie Winters via The National Pulse, Anthony Fauci is...
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
|Average||58.74 (+32.20% Upside)|
|No. of Analysts||22|